L.E.K. Consulting - Behind the Name

What does it take to start a top global management consulting firm? Our global chairman and co-founder Iain Evans, and co-founder Jim Lawrence, sit down to discuss how they met, the early days of L.E.K. Consulting, the principles of the firm and more.

View More Videos »

Global Consumer Insights

When faced with slowing or competitive markets, executives often look overseas for international expansion opportunities. As a global firm, L.E.K. Consulting helps companies select markets for international growth. Take the first step in that journey with our new interactive international expansion map. 

View the Interactive Map »

Thought Leadership

In this Executive Insights, L.E.K. Consulting discusses how retailers can avoid promotional traps by using the benefit-based promotional strategy to garner higher same-store sales and more profitable and incremental sales.

Drawing from his experience advising companies in the building products industry and a recent L.E.K. Consulting Contractor Behavior Study, L.E.K.'s Rob Rourke discusses how e-commerce sites, mobile technology and social media are changing the building and construction industry in the United States.

Drawing from his experience advising companies in the building products industry and a recent L.E.K. survey of 550 residential and commercial contractors, Robert Rourke discusses how e-commerce sites, mobile technology and social media are changing the building and construction industry. - See more at: http://www.lek.com/our-publications/industry-insights#sthash.idLLoCIf.dpuf

In this Executive Insights, President of L.E.K.'s Americas Practice Peter McKelvey lays into a five-step process for effective scenario planning.

This Executive Insights discusses the need for innovation in a shifting healthcare landscape. Like hospital systems, consolidation among MedTechs will almost certainly happen, and survivorship in this area will be determined by innovative services and solutions.

This Executive Insights discusses the need for innovation in a shifting healthcare landscape. Like hospital systems, consolidation among MedTechs will almost certainly happen, and survivorship in this area will be determined by innovative services and solutions. - See more at: http://www.lek.com/knowledge-center#sthash.02pOD3EK.dpuf
This Executive Insights discusses the need for innovation in a shifting healthcare landscape. Like hospital systems, consolidation among MedTechs will almost certainly happen, and survivorship in this area will be determined by innovative services and solutions. - See more at: http://www.lek.com/knowledge-center#sthash.02pOD3EK.dpuf

In this Executive Insights, L.E.K. Consulting argues that the future success of blockbuster branded biologics hinges on the response of three key stakeholder groups who will play a role in biosimilar adoption -- prescribers, patients and payers. Examining these stakeholders in detail, the authors explore a subset of strategies for engagement which underpin an enhanced ability to compete and win in this new and challenging market landscape.

In In this Executive Insights, L.E.K. Consulting argues that the future success of blockbuster branded biologics hinges on the response of three key stakeholder groups  who will play a role in biosimilar adoption—prescribers, patients and payers. Examining these stakeholders in detail, the authors explore a subset of strategies for engagement which underpin an enhanced ability to compete and win in this new and challenging market landscape. - See more at: http://www.lek.com/our-publications/lek-insights/biologics-inflection-point-managing-biosimilar-competition#sthash.lLkN7nP4.dpuf

Big Food has become “big” as a result of a terrific success: their traditional marketing departments have helped generate billions in profits. But relying on one approach to marketing has left these players exposed in today’s fast-moving climate. If a company has only one way to go to market and think about its business, it limits its opportunity to respond quickly, flexibly, and to enter and exit fast-changing food categories in a timely manner. And that’s true for any consumer goods company.

At a time when pharmaceutical firms are contending with an increasingly challenging industry environment, the orphan sector offers the alluring prospect of strong growth and attractive profit margins—along with the opportunity to improve the lives of patients with often debilitating conditions. However, there are several trends that make being a player in orphan drugs a more challenging proposition than in the past.

a
a
a
a
a
a
a